Clinical Trials Directory

Trials / Conditions / Immune System Diseases

Immune System Diseases

103 registered clinical trials studyying Immune System Diseases15 currently recruiting.

StatusTrialSponsorPhase
SuspendedIDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis
NCT06677710
Indapta Therapeutics, INC.Phase 1
Not Yet RecruitingClonal Hematopoiesis of Immunological Significance
NCT05969821
Assistance Publique - Hôpitaux de Paris
RecruitingA Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1
NCT06575426
Otsuka Pharmaceutical Factory, Inc.Phase 1 / Phase 2
Not Yet RecruitingDigital Diagnostics and Intervention Services for Parkinson's Disease
NCT06534177
University of Exeter
RecruitingSupport-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care
NCT05910840
Anne-Sophie BrazeauN/A
RecruitingHIV Engagement and Adolescent Depression Support (HEADS-UP)
NCT06173544
University of North Carolina, Chapel HillN/A
RecruitingAbrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)
NCT06353087
Pfizer
RecruitingImplementation of Support in the Care of Adults Living With Type 1 Diabetes
NCT06069583
McGill UniversityN/A
RecruitingA Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
NCT06271252
OriCell Therapeutics Co., Ltd.Phase 1
WithdrawnThe Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune
NCT06291415
HutchmedPhase 1
CompletedIndividualizing Treatment for Asthma in Primary Care
NCT06272370
DARTNet InstitutePhase 4
Active Not RecruitingGroup Education Trial to Improve Transition for Parents of Adolescents With T1D
NCT05445284
McGill University Health Centre/Research Institute of the McGill University Health CentreN/A
UnknownEpigenetic Memory of Vitamin D Supplementation
NCT06104111
Polish Academy of SciencesPhase 1
CompletedA Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
NCT05928585
HI-Bio, A Biogen CompanyPhase 1
CompletedUkulele Playing to Improve Cognition in People with Multiple Sclerosis: a Feasibility Study
NCT05792176
University of Texas at AustinN/A
RecruitingA Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Di
NCT05787574
Memorial Sloan Kettering Cancer CenterPhase 2
WithdrawnA Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT05431179
Oncternal Therapeutics, IncPhase 3
UnknownEfficacy and Safety of Android Artificial Pancreas System in Adult Patients With Type 1 Diabetes Mellitus in C
NCT05726461
Third Affiliated Hospital, Sun Yat-Sen UniversityN/A
Active Not RecruitingA Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
NCT05621317
Aravax Pty LtdPhase 2
RecruitingAn Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in S
NCT05565248
CRISPR Therapeutics AGPhase 1 / Phase 2
UnknownNext-generation Effects of Vitamin D Supplementation in Pregnancy
NCT05616117
University of Aarhus
TerminatedA Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
NCT05516758
Eli Lilly and CompanyPhase 2
UnknownSensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination
NCT05414890
Beijing Tiantan Hospital
CompletedStudy of Cannabidiol (CBD) in Healthy Volunteers
NCT06286839
NextEvo Inc.N/A
Active Not RecruitingBiodiversity Interventions for Well-Being
NCT06353035
Natural Resources Institute FinlandN/A
CompletedFriendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vie
NCT04790201
University of North Carolina, Chapel HillN/A
CompletedAn Open-Label, FIH Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects Wi
NCT05210530
CRISPR Therapeutics AGPhase 1
CompletedResearch on the Application and Mechanism of New Biological Probes in Biomedicine
NCT04977739
Nanfang Hospital, Southern Medical University
UnknownCOVID-19 Post-Vaccination Observation
NCT06107348
Yang I. Pachankis, PhD
Active Not RecruitingImmuno-Oncology Database and Bioregistry
NCT04656873
UNC Lineberger Comprehensive Cancer Center
CompletedHumoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab T
NCT04837651
Dragonfly Research, LLC
Active Not RecruitingA Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A
NCT04663204
University of LeicesterPhase 2
RecruitingAllogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
NCT04339777
National Cancer Institute (NCI)Phase 2
CompletedA Study of Subcutaneous KY1005 in Healthy Volunteers
NCT04449939
Kymab LimitedPhase 1
WithdrawnRetroviral Insertion Site Methodology Study
NCT03311074
Fondazione TelethonPhase 4
CompletedIs Lymphocyte Subtype Important for Acute Pancreatitis Severity?
NCT04502940
Istanbul Training and Research Hospital
UnknownNatural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma
NCT04309084
Celularity IncorporatedPhase 1
UnknownAnti-viral Effects of Azithromycin in Patients With Asthma and COPD
NCT04319705
Bispebjerg HospitalPhase 4
UnknownNutraceuticals and Functional Foods
NCT05509075
University of Catanzaro
CompletedImpact of HLNatural Immune Supplement on Colds
NCT04103099
Hawthorne Effect Inc.N/A
RecruitingAllogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
NCT03922724
National Cancer Institute (NCI)Phase 2
Active Not RecruitingAnti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
NCT03696784
UNC Lineberger Comprehensive Cancer CenterPhase 1
UnknownExploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
NCT06065592
Lebanese UniversityPhase 1
Active Not RecruitingStudy of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
NCT03672318
UNC Lineberger Comprehensive Cancer CenterPhase 1
Active Not RecruitingStudy of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
NCT03602157
UNC Lineberger Comprehensive Cancer CenterPhase 1
CompletedNo-worry Baby Project
NCT03922087
Sun Yat-sen University
CompletedStudy to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)
NCT03688074
AstraZenecaPhase 2
CompletedRelationship of Endoplasmic Reticulum Stress and Tonsillar Tissue Diseases
NCT04653376
Selcuk University
CompletedStudy Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe At
NCT03720470
PfizerPhase 3
SuspendedCold Water Immersion and Atherosclerosis, Inflammation, Fat Accumulation and Lipid Profile Parameters
NCT04642066
Pavol Jozef Safarik UniversityN/A
Active Not RecruitingAllogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
NCT03663933
National Cancer Institute (NCI)Phase 2
CompletedEffect of Benralizumab in Atopic Dermatitis
NCT03563066
McMaster UniversityPhase 2
CompletedUpper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
NCT03562975
University of South Florida
CompletedStudy to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Se
NCT03627767
PfizerPhase 3
UnknownOral Colostrum and Its Effect on Immune System
NCT03578341
Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesPhase 3
CompletedInvestigating Genetic Risk for Type 1 Diabetes
NCT03503747
University of Oxford
CompletedEffect of Modified Playground Environment on Health, Particularly Immune System
NCT03997175
University of HelsinkiN/A
CompletedMechanism of Action of Ocrelizumab in Multiple Sclerosis
NCT03344094
University of Chicago
UnknownChidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (
NCT03373019
Fudan UniversityPhase 2
CompletedDiamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes
NCT03345004
Diamyd Medical ABPhase 2
CompletedA Study of KY1005 in Healthy Volunteers
NCT03161288
Kymab LimitedPhase 1
CompletedExperimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria
NCT02824393
Celal Bayar UniversityEARLY_Phase 1
CompletedTreatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
NCT02966301
MedsenicPhase 2
CompletedAutologous Tolerogenic Dendritic Cells for Treatment of Patients With Rheumatoid Arthritis
NCT03337165
Russian Academy of Medical SciencesPhase 1
CompletedA Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Spec
NCT02916888
Yale University
Active Not RecruitingStudy of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
NCT02690545
UNC Lineberger Comprehensive Cancer CenterPhase 1 / Phase 2
CompletedBiological Stardadization of D. Pteronyssinus and D. Farinae Allergen Extracts
NCT02527122
Inmunotek S.L.N/A
Active Not RecruitingAdministration of T Lymphocytes for Prevention of Relapse of Lymphomas
NCT02663297
UNC Lineberger Comprehensive Cancer CenterPhase 1
CompletedExercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes
NCT03199638
Nemours Children's ClinicN/A
UnknownOral Immunotherapy in Food Allergy in Finland
NCT02640014
Helsinki University Central HospitalN/A
RecruitingPilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
NCT02579967
National Cancer Institute (NCI)Phase 2
CompletedDetermination of the Sensitivity and Specificity of Prick Test Betula Verrucosa
NCT02527187
Inmunotek S.L.Phase 2
UnknownInvestigating the Immune System in chrONIC Kidney Disease.
NCT02535052
University of Birmingham
CompletedPost-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
NCT02294552
Ivan S MoiseevPhase 2
UnknownDoxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
NCT02203682
Sun Yat-sen UniversityPhase 2
CompletedMicronutrient Supplementation and Incidence of Common Cold
NCT02119143
Green BeatN/A
CompletedThe Effect of Different Volumes of Physical Exercise on the Immune System
NCT02331446
Federal University of PelotasN/A
CompletedTransplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus
NCT02644759
Stem Cells ArabiaPhase 1 / Phase 2
CompletedPharmacokinetics Study of Gamma-aminobutyric Acid
NCT01917760
Huashan Hospital
CompletedSafety Study of CDP7657 in Patients With Systemic Lupus Erythematosus
NCT01764594
UCB PharmaPhase 1
CompletedEfficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
NCT01727973
Sun Yat-sen UniversityPhase 1 / Phase 2
CompletedAsthma Data Innovation Demonstration Project
NCT02162576
David Van SickleN/A
UnknownEfficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic An
NCT01579110
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
Active Not RecruitingAdministration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refract
NCT03016377
UNC Lineberger Comprehensive Cancer CenterPhase 1 / Phase 2
CompletedDiscontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya
NCT01425073
University of WashingtonN/A
CompletedOmalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center
NCT01510626
Stanford UniversityPhase 1
CompletedSingle Center Food Allergy Oral Immunotherapy Study
NCT01490177
Stanford UniversityPhase 1
CompletedAnakinra for Behcet s Disease
NCT01441076
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Phase 1 / Phase 2
CompletedZoster Vaccine Response in the Frail Elderly
NCT01328548
McMaster University
CompletedFeasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM,
NCT02630082
National Institute of Allergy and Infectious Diseases (NIAID)N/A
CompletedMulticenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With C
NCT01222039
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y SaludPhase 1 / Phase 2
CompletedMesalamine to Reduce T Cell Activation in HIV Infection
NCT01090102
University of California, San FranciscoPhase 4
CompletedSafety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
NCT01093911
UCB PharmaPhase 1
CompletedAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple Sclerosi
NCT01056471
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y SaludPhase 1 / Phase 2
UnknownNormal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU)
NCT01319643
University of Modena and Reggio EmiliaPhase 4
CompletedUse of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
NCT01472263
Hospital Universitário Professor Edgard SantosPhase 3
CompletedGenes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory
NCT01161056
Northwell Health
CompletedDeveloping Newborn Screening for Infants With Primary Immunodeficiency
NCT00113464
National Human Genome Research Institute (NHGRI)
CompletedImproving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling
NCT00119548
US Department of Veterans AffairsN/A
TerminatedDietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency
NCT00260299
Oregon Health and Science University
RecruitingNatural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
NCT00006150
National Institute of Allergy and Infectious Diseases (NIAID)
RecruitingActivation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
NCT00001406
National Institute of Allergy and Infectious Diseases (NIAID)
No Longer AvailableCompassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Swit
NCT03594162
UNC Lineberger Comprehensive Cancer Center